Open Beta
MetriLume

US marketsCELZ

SEC-sourced researchBeta

CELZ

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Company comparison ↗

Data passport

CIK
0001187953
Exchange
Nasdaq
Business activity
Biological Products, (No Diagnostic Substances) · SIC 2836
Financial inputs
6/6
Filing date
Nov 13, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 11,000.0000 USD; December 2025: 6,000.0000 USD11K USD0 USD0December 2024December 2025
CELZ · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202411,000.0000Mar 20, 2026
December 20256,000.0000Mar 20, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20256,000.0000-5,995,008.0000-5,856,445.00007,809,525.0000284,880.0000Mar 20, 2026
December 202411,000.0000-5,493,481.0000-5,301,292.00006,669,143.0000327,644.0000Mar 20, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

40/100
Profitability0
Growth5
Balance sheet96
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$6KJan 1, 2025 – Dec 31, 2025Mar 20, 202610-K
Previous period revenueRevenues$11KJan 1, 2024 – Dec 31, 2024Mar 20, 202610-K
Net incomeNetIncomeLoss-$6MJan 1, 2025 – Dec 31, 2025Mar 20, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$5.86MJan 1, 2025 – Dec 31, 2025Mar 20, 202610-K
Total assetsAssets$7.81MDec 31, 2025Mar 20, 202610-K
Total liabilitiesLiabilities$284.88KDec 31, 2025Mar 20, 202610-K

New filings

Explore methodology ↗